US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
CropEnergies AG (0DXG) 銘柄情報

CropEnergies AG (0DXG)

0.00

0.00

(0.00%)

終了 7月11日 12:30AM

CropEnergies AG (0DXG) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

-

( - )

買値

0.00

売値

0.00

出来高

0.00

平均取引量 (3 か月)

1,129 €

財務取引量

-

0.00 日の範囲 0.00

5.27 52 週間の範囲 5.27

時価総額

企業価値

-

前日終値

0.00

始値

-

時刻

最終取引時間

VWAP

-

歳入

1.25B

純利益

65.67M

発行済株式数

87,250,000

浮動株比率 (%)

5.80%

機関投資家保有比率 (%)

0.01%

配当利回り

0.6

PER

18.46

株価売上高倍率 (PSR)

0.97

1 株当たり利益 (EPS)

0.75

ベータ

-0.03

CropEnergies AG manufactures and distributes bioethanol, derivatives, and other products from renewable raw materials in Germany and internationally. The company offers neutral alcohol; protein food and animal feed products, including ProtiGrain, a protein animal feed for ruminants, pigs, poultry an... CropEnergies AG manufactures and distributes bioethanol, derivatives, and other products from renewable raw materials in Germany and internationally. The company offers neutral alcohol; protein food and animal feed products, including ProtiGrain, a protein animal feed for ruminants, pigs, poultry and pets as well as in aquaculture; ProtiWanze, a liquid premium protein; Ensus DDGS, a distillers' dried grains with solubles; and Wheat gluten, a protein for food and feed production. In addition, it offers Biogenic CO2 for the food and pharmaceutical industries; and biobased chemicals, such as ethyl acetate. The company was incorporated in 2006 and is headquartered in Mannheim, Germany. CropEnergies AG operates as a subsidiary of Südzucker AG. 詳細を表示

セクター

Energy

業界

Oil, Gas & Consumable Fuels

ウェブサイト

www.cropenergies.com

本社

Mannheim, Germany

設立

2026

CropEnergies AG is listed in the Energy sector of the ロンドン証券取引所 with ticker 0DXG. The last closing price for CropEnergies was 0.00 €. Over the last year, CropEnergies shares have traded in a share price range of 5.27 € to 5.27 €.

CropEnergies currently has 87,250,000 shares in issue. CropEnergies has a price to earnings ratio (PE ratio) of 18.46.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	5.27	5.27	5.27	573	5.27	DE
52	0	0	5.27	5.27	5.27	369	5.27	DE
156	0	0	5.27	5.27	5.27	8371	5.27	DE
260	0	0	5.27	5.27	5.27	11940	5.27	DE

0DXG - Frequently Asked Questions (FAQ)

What is the current CropEnergies AG share price?

The current share price of CropEnergies AG is 0.00 €

How many CropEnergies AG shares are in issue?

CropEnergies AG has 87,250,000 shares in issue

What is the 1 year trading range for CropEnergies AG share price?

CropEnergies AG has traded in the range of 5.27 € to 5.27 € during the past year

What is the PE ratio of CropEnergies AG?

The price to earnings ratio of CropEnergies AG is 18.46

What is the cash to sales ratio of CropEnergies AG?

The cash to sales ratio of CropEnergies AG is 0.97

What is the registered address of CropEnergies AG?

The registered address for CropEnergies AG is Maximilianstrasse 10, Mannheim, Baden-Württemberg, 68165

What is the CropEnergies AG website address?

The website address for CropEnergies AG is www.cropenergies.com

Which industry sector does CropEnergies AG operate in?

CropEnergies AG operates in the Oil, Gas & Consumable Fuels sector

rosemountbomber

rosemountbomber 16分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 18分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 27分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 37分前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 43分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 44分前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 45分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 49分前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 58分前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 1時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 1時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 1時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

Genz2 1時間前

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 1時間前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

conix 1時間前

Non-promotional information until there is a press release is a wise move.

CatfishHunter

CatfishHunter 1時間前

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

Philosophical Trader

Philosophical Trader 1時間前

How is this doing? This was a great runner with a 2 year cup and handle.

nwtf

nwtf 1時間前

You really dont have a clue what you are talking about. Just stop.

Bitwise Crypto Innovator...

Tagus TEC Title Credits ...

Amundi Core MSCI Emergin...

Exchange Traded Fund Ivz...

Investec Bnk 24

Stellar AfricaGold

Hudson Acquisition I

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。